TerminatedNot Applicable

Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard

Stopped: To much effort needed, high costs for an academic study

Belgium20 participantsStarted 2016-09

Plain-language summary

Evaluate the precision and accuracy of the Proxima 3® System by obtaining quantitative clinical data at various time points. Compare the methods associated with obtaining blood gas results using the Proxima 3® System device versus a conventional ABG analyse. The aim of the investigator is to evaluate the precision and accuracy of the Proxima 3® ABG system parameters (pH, pCO2 pO2, hematocrit and potassium) in clinical practices with rapid changing context.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female patients ≥18 years old * Patients who have (or will have) an arterial line, which was (will be) inserted for clinical - need, will be considered for inclusion in this study * Patients who give informed consent (or their personal/nominated consultee) to participate in the study * Patients who are likely to have an arterial line for at least 6 hours. Exclusion Criteria: * Patients contraindicated for an arterial line * Refusal of consent by a patient * Not for use with patients with uncorrected hyperphosphataemia, hypocalcaemia or hypercalcaemia. * The patient is considered to be unsuitable for the study by the investigator

What they're measuring

Evaluation of accuracy and precision of the Proxima 3® for ABG

Timeframe: From intubation until extubation, max 1 day

Trial details

NCT IDNCT02801162

SponsorUniversitair Ziekenhuis Brussel

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-02

View on ClinicalTrials.gov More Hypoxia trials